- ►chestpubs.org DE Singer, AS Go - Clinics in geriatric medicine, 2001 - Elsevier Based solely on observational data, long-term anticoagulation has been a favored
therapy to prevent stroke in rheumatic AF. 47 It was unclear whether
anticoagulants would work in nonrheumatic AF or whether they would be ... Cited by 554 - Related articles - BL Direct - All 17 versions
- ►oxfordjournals.org PP Karjalainen, P Porela, A Ylitalo, S Vikman … - European Heart Journal, 2007 - Eur Soc Cardiology METHODS AND RESULTS: We analysed retrospectively all consecutive patients on
warfarin therapy (n = 239, mean age 70 years, men 74%) who underwent
percutaneous coronary intervention (PCI) in 2003–04 in six hospitals. An ... Cited by 68 - Related articles - BL Direct - All 3 versions
- Free from Publisher S Schulman, RJ Beyth, C Kearon, MN Levine - Chest, 2008 - chestjournal.chestpubs.org This article about hemorrhagic complications of anticoagulant and thrombolytic
treatment is part of the Antithrombotic and Thrombolytic Therapy: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines ... Cited by 61 - Related articles - All 12 versions
GYH Lip, M Karpha - Chest, 2006 - chestjournal.chestpubs.org Background: There is a lack of published evidence on what is the optimal
management strategy in anticoagulated patients with nonvalvular atrial
fibrillation (AF) who undergo percutaneous coronary intervention (PCI) and, ... Cited by 55 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org JM Ruiz-Nodar, F Marín, JA Hurtado, J … - Journal of the American College of Cardiology, 2008 - Elsevier This study was designed to review outcomes in relation to antithrombotic therapy
management strategies for patients with atrial fibrillation (AF) who undergo
percutaneous coronary intervention (PCI) with stenting. Cited by 43 - Related articles - All 18 versions
D Kubitza, M Becka, W Mueck, M Zuehlsdorf - The Journal of Clinical Pharmacology, 2006 - jclinpharm.highwire.org Rivaroxaban (BAY 59-7939) is an oral, direct Factor Xa inhibitor in advanced
clinical development for the prevention and treatment of thromboembolic
disorders. This was a randomized, 2-way crossover study in healthy male ... Cited by 33 - Related articles - BL Direct - All 7 versions
- ►ecmaj.com JA Delaney, L Opatrny, JM Brophy, S Suissa - Canadian Medical Association Journal, 2007 - ecmaj.com Methods: We conducted a population-based, retrospective case–control study
using records in the United Kingdom General Practice Research Database from 2000
through 2005. Cases were identified as patients over 18 years of age with a ... Cited by 27 - Related articles - BL Direct - All 16 versions
SD Persell, JM Wright, JA Thompson, KS … - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We performed a retrospective electronic medical chart review comparing
automated measurement with a 2-step process of automated measurement
supplemented by review of free-text notes for apparent quality failures for ... Cited by 25 - Related articles - BL Direct - All 4 versions
JW Eikelboom, J Hirsh - Journal of Thrombosis and Haemostasis, 2007 - interscience.wiley.com Summary. The combination of anticoagulant and antiplatelet therapy is more
effective than antiplatelet therapy alone for the initial and long-term
management of acute coronary syndromes but increases the risk of bleeding. ... Cited by 24 - Related articles - BL Direct - All 4 versions
